Hypertrophic cardiomyopathy mutation R58Q in the myosin regulatory light chain perturbs thick filament-based regulation in cardiac muscle.

about

Structural and functional effects of myosin-binding protein-C phosphorylation in heart muscle are not mimicked by serine-to-aspartate substitutions

P2860

Q57157253-72BF37A3-890B-42BC-A29D-9D12AB5AE2B9

P2860

Hypertrophic cardiomyopathy mutation R58Q in the myosin regulatory light chain perturbs thick filament-based regulation in cardiac muscle.

Item

http://www.wikidata.org/entity/Q49923294

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Hypertrophic cardiomyopathy mu ...... regulation in cardiac muscle.

@en

Hypertrophic cardiomyopathy mu ...... regulation in cardiac muscle.

@nl

type

Item

label

Hypertrophic cardiomyopathy mu ...... regulation in cardiac muscle.

@en

Hypertrophic cardiomyopathy mu ...... regulation in cardiac muscle.

@nl

prefLabel

Hypertrophic cardiomyopathy mu ...... regulation in cardiac muscle.

@en

Hypertrophic cardiomyopathy mu ...... regulation in cardiac muscle.

@nl

P1476

Hypertrophic cardiomyopathy mu ...... regulation in cardiac muscle.

@en

P2093

Malcolm Irving

http://www.w3.org/2001/XMLSchema#string

Saraswathi Ponnam

http://www.w3.org/2001/XMLSchema#string

Thomas Kampourakis

http://www.w3.org/2001/XMLSchema#string

P2860

Mutations in beta-myosin S2 that cause familial hypertrophic cardiomyopathy (FHC) abolish the interaction with the regulatory domain of myosin-binding protein-C

Familial hypertrophic cardiomyopathy mutations in the regulatory light chains of myosin affect their structure, Ca2+ binding, and phosphorylation

Skeletal muscle expression and abnormal function of beta-myosin in hypertrophic cardiomyopathy

Three-dimensional image reconstruction of dephosphorylated smooth muscle heavy meromyosin reveals asymmetry in the interaction between myosin heads and placement of subfragment 2

Identification of the genotypes causing hypertrophic cardiomyopathy in northern Sweden

Increased Ca2+-sensitivity of the contractile apparatus in end-stage human heart failure results from altered phosphorylation of contractile proteins

Systematic analysis of the regulatory and essential myosin light chain genes: genetic variants and mutations in hypertrophic cardiomyopathy

Identification of two novel mutations in the ventricular regulatory myosin light chain gene (MYL2) associated with familial and classical forms of hypertrophic cardiomyopathy

Myosin light chain phosphorylation is critical for adaptation to cardiac stress.

Myosin regulatory light chain phosphorylation attenuates cardiac hypertrophy

P304

72-81

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.YJMCC.2018.02.009

http://www.w3.org/2001/XMLSchema#string

P478

117

http://www.w3.org/2001/XMLSchema#string

P577

2018-02-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29452157

http://www.w3.org/2001/XMLSchema#string

P932

5883317

http://www.w3.org/2001/XMLSchema#string

Hypertrophic cardiomyopathy mutation R58Q in the myosin regulatory light chain perturbs thick filament-based regulation in cardiac muscle.

about

P2860

P2860

Hypertrophic cardiomyopathy mutation R58Q in the myosin regulatory light chain perturbs thick filament-based regulation in cardiac muscle.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P932